Abstract
Transient early endosome (EE)-mitochondria interactions can mediate mitochondrial iron translocation, but the associated mechanisms are still elusive. We showed that Divalent Metal Transporter 1 (DMT1) sustains mitochondrial iron translocation via EE-mitochondria interactions in triple-negative MDA-MB-231, but not in luminal A T47D breast cancer cells. DMT1 silencing increases labile iron pool (LIP) levels and activates PINK1/Parkin-dependent mitophagy in MDA-MB-231 cells. Mitochondrial bioenergetics and the iron-associated protein profile were altered by DMT1 silencing and rescued by DMT1 re-expression. Transcriptomic profiles upon DMT1 silencing are strikingly different between 2D and 3D culture conditions, suggesting that the environment context is crucial for the DMT1 knockout phenotype observed in MDA-MB-231 cells. Lastly, in vivo lung metastasis assay revealed that DMT1 silencing promoted the outgrowth of lung metastatic nodules in both human and murine models of triple-negative breast cancer cells. These findings reveal a DMT1-dependent pathway connecting EE-mitochondria interactions to mitochondrial iron translocation and metastatic fitness of breast cancer cells.
Introduction
Cancer cells are "iron-hungry," requiring high levels of the metal for DNA synthesis and energy production. Mitochondria are the primary site where iron is processed into heme and iron-sulfur clusters. Traditionally, it was thought that iron was released into the cytosol before being picked up by mitochondria. However, a more efficient "kiss-and-run" mechanism—where iron-carrying endosomes physically touch mitochondria to transfer cargo—has been observed. This study identifies DMT1 as the molecular bridge facilitating this direct transfer and explores how its disruption impacts metastatic potential in breast cancer.
Methods
The researchers employed CRISPR/Cas9 to knock out the SLC11A2 gene (encoding DMT1) in MDA-MB-231 (TNBC) and T47D (Luminal A) breast cancer cells. They used high-resolution imaging to quantify the Surface Contact Area (SCA) between endosomes and mitochondria. Mitochondrial iron translocation was measured using the RDA probe, while the cytosolic Labile Iron Pool (LIP) was tracked with FerroOrange. Additionally, bioenergetics were assessed via Seahorse XF assays, and metastatic potential was evaluated using 3D spheroids and in vivo lung colonization models.
Results
DMT1 as the Molecular Bridge
DMT1 localizes to both the endosome and the outer mitochondrial membrane, acting as a physical tether. This mechanism is essential for TNBC cells (MDA-MB-231) but not for Luminal A cells (T47D), suggesting distinct iron handling logistics across breast cancer subtypes.
Reduced Interaction and Metabolic Stress
Quantification of imaging data showed that DMT1 knockout led to a significant decrease in the total contact area (SCA) between endosomes and mitochondria in TNBC cells, but not in Luminal A cells.
This impaired interaction delayed mitochondrial iron uptake, leading to reduced ATP production and the activation of mitophagy. Paradoxically, because iron was not entering the mitochondria, it accumulated in the cytosol (increased LIP).
Enhanced Metastatic Fitness
This cytosolic iron buildup and metabolic rewiring made TNBC cells more aggressive in metastatic environments. In mouse models, DMT1-deficient cells formed larger lung nodules. Clinical analysis of TCGA data confirmed that lower DMT1 expression in TNBC is associated with worse overall survival, supporting the experimental finding that low DMT1 promotes metastatic outgrowth.
Conclusion
The study reveals a DMT1-dependent pathway connecting endosome-mitochondria interactions to mitochondrial iron translocation. While silencing DMT1 impairs mitochondrial function, the resulting increase in cytosolic iron promotes metastatic fitness in triple-negative breast cancer. These findings emphasize the importance of the 3D microenvironment in cancer biology and suggest that targeting the cytosolic iron pool may be a potential therapeutic avenue.
Summary updated